Delivery Order SPE2DB22D2006-SPE2DB24FW3CS

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,496.37, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The order has an ultimate completion date of April 20, 2023 and was awarded on April 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,820.64 contract is for the supply of ENGERIX-B 20 MCG/ML VIALML, a hepatitis B vaccine. This delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The $6,642.40 firm fixed-price contract has an ultimate completion date of August 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The total ceiling value of the order is $1,354.96, with a period of performance through March 19, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $1,693.70 contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals, medical supplies,...
The U.S. Defense Logistics Agency (DLA) awarded a $3,796.56 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,565,744,243 units of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a ceiling value of $5,501.12 and a period of performance through April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,820.64 award is for the supply of ENGERIX-B 20 MCG/ML VIALML, a hepatitis B vaccine. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen Drug Corp to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a firm fixed price of $2,657.05 and a completion date of July 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, at a ceiling value of $16,606.00. The contract is a firm fixed-price delivery order with an ultimate completion date of May 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW3CS
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,519.95, is for the supply of Engerix-B 20 mcg/mL hepatitis B vaccine. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by August 27, 2024.

Generated 11/25/24, 9:03 AM